NO893270D0 - Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater.Info
- Publication number
- NO893270D0 NO893270D0 NO893270A NO893270A NO893270D0 NO 893270 D0 NO893270 D0 NO 893270D0 NO 893270 A NO893270 A NO 893270A NO 893270 A NO893270 A NO 893270A NO 893270 D0 NO893270 D0 NO 893270D0
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- acetic acid
- acid derivatives
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3827727A DE3827727A1 (de) | 1988-08-16 | 1988-08-16 | Anellierte tetrahydropyridinessigsaeurederivate, verfahren zu deren herstellung und verwendung solcher verbindungen zur kardioprotektion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO893270D0 true NO893270D0 (no) | 1989-08-15 |
| NO893270L NO893270L (no) | 1990-02-19 |
Family
ID=6360928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89893270A NO893270L (no) | 1988-08-16 | 1989-08-15 | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0358957A1 (no) |
| JP (1) | JPH02160767A (no) |
| KR (1) | KR900003129A (no) |
| AU (1) | AU637767B2 (no) |
| DD (3) | DD285595A5 (no) |
| DE (1) | DE3827727A1 (no) |
| DK (1) | DK399789A (no) |
| FI (1) | FI893832A (no) |
| HU (1) | HU208434B (no) |
| IL (1) | IL91301A0 (no) |
| NO (1) | NO893270L (no) |
| PH (1) | PH27356A (no) |
| PL (1) | PL161521B1 (no) |
| PT (1) | PT91451A (no) |
| YU (1) | YU160189A (no) |
| ZA (1) | ZA896205B (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5162336A (en) * | 1990-06-21 | 1992-11-10 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Tetrahydro-pyrido-indoles as cholecystokinin and gastrin antagonists |
| DE4041482A1 (de) * | 1990-12-22 | 1992-06-25 | Boehringer Ingelheim Kg | Neue pharmazeutische verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine |
| DE4104257A1 (de) * | 1991-02-13 | 1992-08-20 | Boehringer Ingelheim Kg | Verwendung von anellierten tetrahydropyridinessigsaeurederivaten fuer die behandlung neurologischer erkrankungen |
| EP0957092A1 (de) * | 1992-06-22 | 1999-11-17 | Boehringer Ingelheim Pharma KG | Anellierte Dihydropyridine und deren Verwendung für die Herstellung von pharmazeutischen Zubereitungen |
| US5674878A (en) * | 1992-06-22 | 1997-10-07 | Boehringer Ingelheim Kg | Anellated dihydropyridines and the use thereof for the production of pharmaceutical preparations |
| EP0620222A3 (en) * | 1993-04-14 | 1995-04-12 | Lilly Co Eli | Tetrahydro-beta-carbolines. |
| DE4343683A1 (de) * | 1993-12-21 | 1995-06-22 | Boehringer Ingelheim Kg | Anellierte Dihydropyridine und deren Verwendung für die Herstellung von pharmazeutischen Zubereitungen |
| DE4343641A1 (de) * | 1993-12-21 | 1995-06-29 | Boehringer Ingelheim Kg | Anellierte Dihydropyridine und deren Verwendung für die Herstellung von pharmazeutischen Zubereitungen |
| PL315052A1 (en) * | 1993-12-21 | 1996-09-30 | Boehringer Ingelheim Kg | Condensed dihydropyridines, method of obtaining them, their application in producing pharmaceutic preparations and pharmaceutic preparations containing such compounds |
| WO2000051998A1 (en) | 1999-03-02 | 2000-09-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as reversible inhibitors of cathepsin s |
| US6420364B1 (en) | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
| IL162310A0 (en) | 2001-12-19 | 2005-11-20 | Lundbeck & Co As H | 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives |
| GB2422828A (en) * | 2005-02-03 | 2006-08-09 | Hunter Fleming Ltd | Tricyclic cytoprotective compounds comprising an indole residue |
| RU2641648C1 (ru) | 2009-12-04 | 2018-01-19 | Суновион Фармасьютикалз, Инк. | Полициклические соединения и способы их применения |
| KR20190065246A (ko) | 2016-07-29 | 2019-06-11 | 선오비온 파마슈티컬스 인코포레이티드 | 화합물 및 조성물 및 이들의 용도 |
| CN116283877A (zh) | 2016-07-29 | 2023-06-23 | 赛诺维信制药公司 | 化合物、组合物及其用途 |
| MX2019009763A (es) | 2017-02-16 | 2019-11-21 | Sunovion Pharmaceuticals Inc | Metodos para tratar esquizofrenia. |
| SG11202000669VA (en) | 2017-08-02 | 2020-02-27 | Sunovion Pharmaceuticals Inc | Isochroman compounds and uses thereof |
| WO2019161238A1 (en) | 2018-02-16 | 2019-08-22 | Sunovion Pharmaceuticals Inc. | Salts, crystal forms, and production methods thereof |
| AU2020236225A1 (en) | 2019-03-14 | 2021-09-16 | Sunovion Pharmaceuticals Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
| KR20230003503A (ko) | 2020-04-14 | 2023-01-06 | 선오비온 파마슈티컬스 인코포레이티드 | 신경학적 및 정신의학적 장애의 치료를 위한 (S)-(4,5-디히드로-7H-티에노[2,3-c]피란-7-일)-N-메틸메탄아민 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3021331A (en) * | 1959-07-20 | 1962-02-13 | Pfizer & Co C | Azabenzopyridocolines |
| DE2361390A1 (de) * | 1973-12-10 | 1975-06-19 | Merck Patent Gmbh | Isochinolinderivate und verfahren zu ihrer herstellung |
| HU174697B (hu) * | 1976-12-30 | 1980-03-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 6,7-dimetoksi-1,2,3,4-tetragidro-1-izokinolin-acetamida |
| FR2447921A1 (fr) * | 1979-02-05 | 1980-08-29 | Synthelabo | Imidazo et pyrimido-pyrido-indoles et leur application en therapeutique |
| FR2455044A1 (fr) * | 1979-04-26 | 1980-11-21 | Synthelabo | Pyrido-indoles et leur application en therapeutique |
| DE3013906A1 (de) * | 1980-04-11 | 1981-10-15 | C.H. Boehringer Sohn, 6507 Ingelheim | Substituierte (alpha) -aminocarbonyl-l-benzyl-3,4-dihydro-isochinoline, verfahren zu deren herstellung und deren verwendung |
| DE3309596A1 (de) * | 1982-08-05 | 1984-04-05 | Basf Ag, 6700 Ludwigshafen | 2-substituierte 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-ss-carboline, ihre herstellung und verwendung als arzneimittel |
| DE3229215A1 (de) * | 1982-08-05 | 1984-02-09 | Basf Ag, 6700 Ludwigshafen | 1-(halogenalkyl)-1,2,3,4-tetrahydro-ss-carboline, ihre herstellung und verwendung |
| DE3621413A1 (de) * | 1986-06-26 | 1988-01-07 | Boehringer Ingelheim Kg | Verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine als cardioprotektive mittel sowie neue heterocyclisch und carbocyclisch anellierte dihydropyridine, verfahren zu deren herstellung und zwischenstufen fuer deren herstellung |
| IL86131A0 (en) * | 1987-04-24 | 1988-11-15 | Boehringer Ingelheim Kg | Benzo-and thieno-3,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them |
-
1988
- 1988-08-16 DE DE3827727A patent/DE3827727A1/de not_active Ceased
-
1989
- 1989-08-11 EP EP89114943A patent/EP0358957A1/de not_active Withdrawn
- 1989-08-14 PT PT91451A patent/PT91451A/pt not_active Application Discontinuation
- 1989-08-14 KR KR1019890011572A patent/KR900003129A/ko not_active Application Discontinuation
- 1989-08-14 IL IL91301A patent/IL91301A0/xx unknown
- 1989-08-15 ZA ZA896205A patent/ZA896205B/xx unknown
- 1989-08-15 NO NO89893270A patent/NO893270L/no unknown
- 1989-08-15 JP JP1210567A patent/JPH02160767A/ja active Pending
- 1989-08-15 YU YU160189A patent/YU160189A/sh unknown
- 1989-08-15 DK DK399789A patent/DK399789A/da not_active Application Discontinuation
- 1989-08-15 FI FI893832A patent/FI893832A/fi not_active Application Discontinuation
- 1989-08-15 HU HU894200A patent/HU208434B/hu not_active IP Right Cessation
- 1989-08-16 PL PL89281066A patent/PL161521B1/pl unknown
- 1989-08-16 AU AU39925/89A patent/AU637767B2/en not_active Withdrawn - After Issue
- 1989-08-16 PH PH39103A patent/PH27356A/en unknown
- 1989-08-16 DD DD89331836A patent/DD285595A5/de not_active IP Right Cessation
- 1989-08-16 DD DD89343927A patent/DD297640A5/de not_active IP Right Cessation
- 1989-08-16 DD DD89343928A patent/DD295379A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3992589A (en) | 1990-02-22 |
| HUT51277A (en) | 1990-04-28 |
| ZA896205B (en) | 1991-04-24 |
| FI893832A (fi) | 1990-02-17 |
| AU637767B2 (en) | 1993-06-10 |
| PH27356A (en) | 1993-06-22 |
| DD297640A5 (de) | 1992-01-16 |
| YU160189A (sh) | 1992-09-07 |
| DK399789D0 (da) | 1989-08-15 |
| IL91301A0 (en) | 1990-03-19 |
| DE3827727A1 (de) | 1990-02-22 |
| PL161521B1 (pl) | 1993-07-30 |
| HU208434B (en) | 1993-10-28 |
| DD285595A5 (de) | 1990-12-19 |
| NO893270L (no) | 1990-02-19 |
| JPH02160767A (ja) | 1990-06-20 |
| PT91451A (pt) | 1990-03-08 |
| EP0358957A1 (de) | 1990-03-21 |
| DD295379A5 (de) | 1991-10-31 |
| KR900003129A (ko) | 1990-03-23 |
| DK399789A (da) | 1990-02-17 |
| FI893832A0 (fi) | 1989-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO894630L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO864425D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater. | |
| NO882732D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO904694D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO901684L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO893270L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater. | |
| NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO883122D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
| NO875488L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO891114L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
| NO881884D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater. | |
| NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
| NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. | |
| NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO168825C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO890724L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. | |
| NO890519D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater. | |
| NO863005D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater. | |
| NO162239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater. | |
| NO860065L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminofenolderivater. |